You've finished learning about Topic 2: Pharmacokinetics.

The key points to remember are:

	The design of NuvaRing® provides a steady release of EE and ENG, thus achieving fairly constant blood levels throughout the 21 days of use.
	There is no known change in effectiveness when NuvaRing® is used in combination with vaginal creams.

 

Click HERE to return to the Topic Menu, or click Next to begin Topic 4: Indications and Usage.